000 | 01936 a2200481 4500 | ||
---|---|---|---|
005 | 20250517095037.0 | ||
264 | 0 | _c20170209 | |
008 | 201702s 0 0 eng d | ||
022 | _a1421-9778 | ||
024 | 7 |
_a10.1159/000445587 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Li-Ping | |
245 | 0 | 0 |
_aCombination Therapy of Nifedipine and Sulphonylureas Exhibits a Mutual Antagonistic Effect on the Endothelial Cell Dysfunction Induced by Hyperglycemia Linked to Vascular Disease. _h[electronic resource] |
260 |
_bCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology _c2016 |
||
300 |
_a2337-47 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aDiabetic Angiopathies _xcomplications |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 |
_aGlyburide _xpharmacology |
650 | 0 | 4 | _aHuman Umbilical Vein Endothelial Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperglycemia _xcomplications |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 | _aIrbesartan |
650 | 0 | 4 |
_aMetformin _xpharmacology |
650 | 0 | 4 |
_aNifedipine _xpharmacology |
650 | 0 | 4 |
_aOxygen _xmetabolism |
650 | 0 | 4 |
_aSulfonylurea Compounds _xpharmacology |
650 | 0 | 4 |
_aTetrazoles _xpharmacology |
700 | 1 | _aJiang, Yu | |
700 | 1 | _aYang, Hong | |
700 | 1 | _aPeng, Cheng | |
700 | 1 | _aZhang, Chuan | |
700 | 1 | _aTao, Xia | |
700 | 1 | _aXie, He-Hui | |
773 | 0 |
_tCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology _gvol. 38 _gno. 6 _gp. 2337-47 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000445587 _zAvailable from publisher's website |
999 |
_c26037265 _d26037265 |